| Autor: |
Bamshad, David, Sanghvi, Jay, Galla, Naveen, Geffner, Adam, Menon, Kartikeya, Bishay, Vivian, Shilo, Dan, Garcia-Reyes, Kirema, Lookstein, Robert, Rastinehad, Ardeshir, Fischman, Aaron |
| Zdroj: |
Journal of Vascular & Interventional Radiology; Dec2024, Vol. 35 Issue 12, p1855-1861, 7p |
| Abstrakt: |
This retrospective study evaluated the feasibility, safety, and short-term effectiveness of prostatic artery embolization (PAE) using n -butyl cyanoacrylate (n BCA) glue embolization in 244 patients from June 2022 through May 2024. Technical success, defined as bilateral glue embolization, was achieved in 95% of cases. The median fluoroscopy time was 22.2 minutes (interquartile range [IQR], 17.1–30.0 minutes), and the median air kerma was 753 mGy (IQR, 417–1,559 mGy). Compared with baseline, statistically significant improvements were observed at 7.1 weeks for the International Prostate Symptom Score (9.5 [SD ± 6.0] vs 20.5 [SD ± 6.7]; P <.01), quality of life (1.8 [SD ± 1.5] vs 4.0 [SD ± 1.1]; P <.01), Q max (10.4 mL/s [SD ± 6.3] vs 6.1 mL/s [SD ± 2.5]; P <.01), and prostate grand volume at 6 months (113.3 mL [SD ± 69.3] vs 156.6 mL [SD ± 104.6]; P <.01). These results demonstrate the use of n BCA for PAE as a technically feasible and safe option with excellent short-term outcomes. [Display omitted] [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
